GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Heron Therapeutics Inc. (HRTX) [hlAlert]

Rating:
Buy HRTX
up 23.20 %

Heron Therapeutics Inc. (HRTX) rated Buy with price target $45 by Lake Street

Posted on: Thursday,  Dec 10, 2015  9:25 AM ET by Lake Street

Lake Street rated Buy Heron Therapeutics Inc. (NASDAQ: HRTX) on 12/10/2015, when the stock price was $27.11. Since
then, Heron Therapeutics Inc. has gained 23.20% as of 01/19/2016's recent price of $33.40.
If you would have followed this Lake Street's recommendation on HRTX, you would have gained 23.2% of your investment in 40 days.

A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company focused on developing pharmaceutical products using its Biochronomer polymer-based drug delivery technology. The Company?s primary focus is on its lead product candidate, APF530, which completed a pivotal Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting (CINV) during the year ended December 31, 2008. APF530 is designed to prevent CINV for at least five days and contains granisetron, a drug approved for the prevention of CINV. In addition to its lead drug candidate, A.P. Pharma has a pipeline of other product candidates that use its Biochronomer technology. One of these, APF112, incorporates the local anesthetic, mepivacaine. It is designed to provide up to 36 hours of post-surgical pain relief and to minimize the use of morphine-like drugs, or opiates, which are used in post-surgical pain management.

Lake Street
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2015 9:25 AM Buy
None
27.11 45.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy